Search results
Results from the WOW.Com Content Network
This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court, the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI). While the Federal Circuit (CAFC) sits below the Supreme Court ...
Schillinger v. United States: 155 U.S. 163: 1894: Patent infringement claim against the United States cannot be asserted. Black Diamond Coal Mining Company v. Excelsior Coal Company: 156 U.S. 611: 1895: Consolidated Electric Light Co v. McKeesport Light Co: 159 U.S. 465: 1895: Risdon Iron & Locomotive Works v. Medart: 158 U.S. 68: 1895: Boyden ...
Patent Application Information Retrieval (PAIR) is an online service provided by the United States Patent and Trademark Office to allow users to see the prosecution histories of United States patents and patent applications and obtain copies of documents filed therein. There are two services: Public PAIR, which allows the general public to ...
MedImmune was a licensee of the later Cabilly patent, but argued that the term had been improperly extended and that it need not continue to pay royalties past the original expiry date in March 2006. The case was decided in favor of MedImmune, and the United States Patent and Trademark Office (USPTO) declared the patent invalid. Genentech ...
Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005), [1] was a case decided by the US Court of Appeals for the Federal Circuit en banc, that clarified the hierarchy of evidentiary sources usable for claim construction in patent law. [2]
Apple Inc. litigation (multiple, multinational cases) Apple v. HTC (US, 2010) Apple Inc. v. Samsung Electronics Co., Ltd. (multiple, multinational cases, ongoing [citation needed]) Ariad v. Lilly (US, 2006) Arizona Cartridge Remanufacturers Association Inc. v. Lexmark International Inc. (US, 2005) Association for Molecular Pathology v. Myriad ...
A U.S. Patent Office tribunal on Monday rejected challenges to two key patents owned by Novo Nordisk covering the active ingredient in its weight-loss and diabetes drugs Wegovy and Ozempic brought ...
The United States Congress, however, can change the patent laws and thus override a decision of the Supreme Court. An alternative path was a civil action against the Director of the United States Patent and Trademark Office in the U.S. District Court for the District of Columbia under 35 U.S.C. § 145.